[1]
A. Heidari, “Active targeting of rhenium (iv) oxide (ReO2), rhenium trioxide (ReO3) and rhenium (vii) oxide (Re2O7) nanoparticles as cancer therapeutics swell-up to kill cancer cells under synchrotron and synchrocyclotron radiations”, IJAC, vol. 9, no. 2, pp. 103–121, Sep. 2021, doi: 10.14419/ijac.v9i2.31656.